GT
SYRS

Glenmede Trust’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Glenmede Trust’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-932
Closed -$148K – 2862
2017
Q2 		$148K Hold
932
– – ﹤0.01% 1287
2017
Q1 		$148K Hold
932
– – ﹤0.01% 1287
2016
Q4 		$113K Hold
932
– – ﹤0.01% 1371
2016
Q3 		$129K Buy
+932
New +$129K ﹤0.01% 1324